Abstract
This report provides a comprehensive analysis of the global Nitrocellulose (NC) Membrane market, projecting steady growth through 2032. Primarily utilized in lateral flow assays for medical diagnostics and point-of-care testing, the market is driven by increasing demand for home testing, multiplexed detection, and high-throughput automation. The study examines key segments by thickness, material, and wicking rate, while highlighting the dominance of the Asia-Pacific region and the competitive landscape among leading global manufacturers.
Related Questions
US$ 101 million in 2025; US$ 171 million in 2032
8.6% CAGR (2026-2032)
Merck, Sartorius, Danaher (Cytiva), AMD (MDI), Suzhou Tianren, Advantec, Advanced Microdevices (MDI), Equinox Biotech, Tianren, Zhejiang Tailin Bioengineering, BSK Basic, Beijia New Material, Kingfa, Cobetter
High-throughput, automated, and standardized membranes; Diversified testing product portfolios; Improving sensitivity and specificity through capillary action and pore structure
Summary
Market Overview
Market Size and Growth Projections
The global Nitrocellulose (NC) Membrane market is projected to grow from US$ 101 million in 2025 to US$ 171 million in 2032, representing a compound annual growth rate (CAGR) of 8.6% from 2026 to 2032.
Product Definition and Functionality
In the context of this report, Nitrocellulose (NC) membrane primarily refers to analytical/reaction membranes, typically consisting of nitrocellulose (NC) laminated onto a backing. These materials serve as porous, capillary-driven substrates used in lateral flow test strips to enable liquid transport and immunoreaction.
Key functional characteristics include:
- Capillary Action: Strong capillary action allows for the lateral migration of liquid samples.
- Protein Binding: High protein binding capacity enables the capture and immobilization of biological reagents on both test and control lines.
- Signal Generation: As samples migrate, labeled detection conjugates (such as gold, latex, or fluorescent particles) form complexes with target analytes. These complexes are captured on the test line to generate a visible or quantifiable signal, while the control line confirms proper flow and reagent functionality.
Industry Economics and Production
Profitability and Pricing
- Gross Profit Margin: In 2025, the global Nitrocellulose (NC) membrane industry's gross profit margin was approximately 44.36% to 59.54%.
- Pricing Units: Depending on the product form, units of measurement include "rolls" (100 meters per roll), "sheets," or "square meters" (1 square meter per sheet).
- Retail Pricing: Prices vary by specification, with retail prices ranging from approximately $100 to $285 per roll. Leading international companies generally command higher prices compared to Chinese manufacturers.
Production and Capacity
- Capacity Variance: Production scales vary significantly; some small businesses operate a single production line producing 3,000 rolls per month, while larger entities produce approximately 300,000 square meters annually.
- Usage Metric: This report calculates usage based on "test counts," with global Nitrocellulose (NC) Membrane production projected to reach 9,556 million tests by 2025.
Value Chain
- Upstream (Raw Materials & Equipment):
- Materials: Cellulose (nitrocellulose, cellulose acetate, wetting agent liquid), solvents (methyl acetate, ethanol, dibutanol), PET film, and glassine paper.
- Equipment: Coating and cutting equipment, quality testing equipment, etc.
- Downstream: In vitro diagnostics (IVD) and point-of-care testing (POCT) companies.
Market Trends
1. Post-Pandemic Correction: In 2023 and 2024, as the impact of the pandemic subsided, both product sales volume and prices declined, resulting in total market revenue in 2024 being lower than in 2021. 2. Thickness Segmentation: Products are categorized by thickness (≤ 250 µm and > 250 µm). Membranes with a thickness of no more than 250 µm maintain applications in both 2024 and 2025; specifically, 250 µm NC membranes are expected to account for 89.3% of the global sales market share in 2025. 3. Application Dominance: While applications are diverse, the medical diagnostics and point-of-care testing (POC) sector is the most widely used, projected to account for approximately 79.82% of the global market size by 2025. 4. Key Suppliers: The United States, the European Union, China, and India are the primary global suppliers. 5. Regional Leadership: The Asia-Pacific region has been the largest global market for several years and is expected to continue growing. By 2024, Asia-Pacific is projected to hold approximately 41.54% of the global market share, followed by Europe (27.63%) and North America (23.83%). 6. Competitive Concentration: Major manufacturers include Merck, Sartorius, Danaher (Cytiva), AMD (MDI), and Suzhou Tianren. The top five manufacturers are projected to control approximately 80.15% of the global market share by 2025.
Strategic Market Drivers
Multi-Scenario, Long-Cycle Consumption
Following the COVID-19 peak, lateral flow immunoassay (LFA) demand has stabilized across infectious diseases, women's health, drug abuse, food safety, and veterinary testing. Future demand will be driven by diversified testing portfolios rather than single blockbuster products, placing higher importance on supply continuity and batch-to-batch consistency.
Home Testing and Retail Expansion
Home testing (particularly for women's health and respiratory infections) is a primary demand driver. This shift is driving NC membrane development toward high-throughput roll-to-roll supply, automation-friendly specifications, and stricter control over capillary rate variations and background values. In the mature Human Chorionic Gonadotropin (HCG) testing market, companies are competing via price and cost reductions, primarily utilizing 20mm or 18mm pure NC products.
Sensitivity and Detection Limits
Recent LFA development focuses on improving sensitivity and specificity through signal enhancement, sample enrichment, and advanced labeling. This necessitates membranes that balance speed and performance by optimizing capillary action time (slower times often improve sensitivity), pore structure, and surfactant treatments.
Multiplex Detection
Advancements in detecting multiple targets on a single strip/cassette require membranes with uniform surface chemistry/porosity, consistent multi-strip performance, lower background, and stable lateral flow characteristics, leading to more segmented membrane portfolios.
Automation and Standardization
Demand is rising for high-throughput, automated, and standardized membranes driven by multiplexing, digital readings, and POCT applications in public health, food safety, and environmental monitoring. Competitive advantage will belong to suppliers capable of scaling production while ensuring quality and supply chain resilience.
Market Segmentation
By Type
- Thickness max. 250 µm
- Thickness above 250 µm
By Material
- Polyester‑backed NC
- Unbacked Nitrocellulose (NC)
By Wicking Rate (s/4 cm)
- Standard-Flow (Medium): 100–140s/4cm
- High-Flow (Fast): <100s/4cm
- Low-Flow (Slow): >140s/4cm
By Application
- Medical Diagnostics and Point-of-Care (POC)
- Drug of Abuse Testing
- Food Safety and Environmental
- Other Applications
By Geography
- Americas: United States, Canada, Mexico, Brazil
- APAC: China, Japan, Korea, Southeast Asia, India, Australia
- Europe: Germany, France, UK, Italy, Russia
- Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries
Competitive Landscape
Major Manufacturers:
- Merck
- Sartorius
- Danaher (Cytiva)
- Advantec
- Advanced Microdevices (MDI)
- Equinox Biotech
- Tianren
- Zhejiang Tailin Bioengineering
- BSK Basic
- Beijia New Material
- Kingfa
- Cobetter
Report Scope and Methodology
This LP Information, Inc. (LPI) research report, titled "Nitrocellulose (NC) Membrane Industry Forecast," provides a comprehensive analysis of the global landscape, including past sales, 2025 reviews, and projections for 2026 through 2032. The report analyzes:
- Product segmentation, company formation, revenue, and market share.
- Latest developments and M&A activity.
- Leading company strategies regarding portfolios, market entry, positions, and geographic footprints.
- Emerging pockets of opportunity using a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs.
Key Questions Addressed
- What is the 10-year outlook for the global Nitrocellulose (NC) Membrane market?
- What factors are driving Nitrocellulose (NC) Membrane market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Nitrocellulose (NC) Membrane market opportunities vary by end market size?
- How does Nitrocellulose (NC) Membrane break out by Type and by Application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nitrocellulose (CN) Membrane Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nitrocellulose (CN) Membrane by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nitrocellulose (CN) Membrane by Country/Region, 2021, 2025 & 2032
2.2 Nitrocellulose (CN) Membrane Segment by Type
2.2.1 Micro Filtration Membrane
2.2.2 Ultrafiltration Membrane
2.2.3 Other
2.2.4 Nitrocellulose (CN) Membrane Sales by Type
- 2.2.4.1 Global Nitrocellulose (CN) Membrane Sales Market Share by Type (2021-2026)
- 2.2.4.2 Global Nitrocellulose (CN) Membrane Revenue and Market Share by Type (2021-2026)
- 2.2.4.3 Global Nitrocellulose (CN) Membrane Sale Price by Type (2021-2026)
2.3 Nitrocellulose (CN) Membrane Segment by Application
2.3.1 BioPharmaceutical
2.3.2 Food and Drinks
2.3.3 Other
2.3.4 Nitrocellulose (CN) Membrane Sales by Application
- 2.3.4.1 Global Nitrocellulose (CN) Membrane Sale Market Share by Application (2021-2026)
- 2.3.4.2 Global Nitrocellulose (CN) Membrane Revenue and Market Share by Application (2021-2026)
- 2.3.4.3 Global Nitrocellulose (CN) Membrane Sale Price by Application (2021-2026)
3 Global by Company
3.1 Global Nitrocellulose (CN) Membrane Breakdown Data by Company
3.1.1 Global Nitrocellulose (CN) Membrane Annual Sales by Company (2021-2026)
3.1.2 Global Nitrocellulose (CN) Membrane Sales Market Share by Company (2021-2026)
3.2 Global Nitrocellulose (CN) Membrane Annual Revenue by Company (2021-2026)
3.2.1 Global Nitrocellulose (CN) Membrane Revenue by Company (2021-2026)
3.2.2 Global Nitrocellulose (CN) Membrane Revenue Market Share by Company (2021-2026)
3.3 Global Nitrocellulose (CN) Membrane Sale Price by Company
3.4 Key Manufacturers Nitrocellulose (CN) Membrane Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nitrocellulose (CN) Membrane Product Location Distribution
3.4.2 Players Nitrocellulose (CN) Membrane Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Nitrocellulose (CN) Membrane by Geographic Region
4.1 World Historic Nitrocellulose (CN) Membrane Market Size by Geographic Region (2021-2026)
4.1.1 Global Nitrocellulose (CN) Membrane Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nitrocellulose (CN) Membrane Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nitrocellulose (CN) Membrane Market Size by Country/Region (2021-2026)
4.2.1 Global Nitrocellulose (CN) Membrane Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nitrocellulose (CN) Membrane Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nitrocellulose (CN) Membrane Sales Growth
4.4 APAC Nitrocellulose (CN) Membrane Sales Growth
4.5 Europe Nitrocellulose (CN) Membrane Sales Growth
4.6 Middle East & Africa Nitrocellulose (CN) Membrane Sales Growth
5 Americas
5.1 Americas Nitrocellulose (CN) Membrane Sales by Country
5.1.1 Americas Nitrocellulose (CN) Membrane Sales by Country (2021-2026)
5.1.2 Americas Nitrocellulose (CN) Membrane Revenue by Country (2021-2026)
5.2 Americas Nitrocellulose (CN) Membrane Sales by Type (2021-2026)
5.3 Americas Nitrocellulose (CN) Membrane Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nitrocellulose (CN) Membrane Sales by Region
6.1.1 APAC Nitrocellulose (CN) Membrane Sales by Region (2021-2026)
6.1.2 APAC Nitrocellulose (CN) Membrane Revenue by Region (2021-2026)
6.2 APAC Nitrocellulose (CN) Membrane Sales by Type (2021-2026)
6.3 APAC Nitrocellulose (CN) Membrane Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nitrocellulose (CN) Membrane by Country
7.1.1 Europe Nitrocellulose (CN) Membrane Sales by Country (2021-2026)
7.1.2 Europe Nitrocellulose (CN) Membrane Revenue by Country (2021-2026)
7.2 Europe Nitrocellulose (CN) Membrane Sales by Type (2021-2026)
7.3 Europe Nitrocellulose (CN) Membrane Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nitrocellulose (CN) Membrane by Country
8.1.1 Middle East & Africa Nitrocellulose (CN) Membrane Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nitrocellulose (CN) Membrane Revenue by Country (2021-2026)
8.2 Middle East & Africa Nitrocellulose (CN) Membrane Sales by Type (2021-2026)
8.3 Middle East & Africa Nitrocellulose (CN) Membrane Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nitrocellulose (CN) Membrane
10.3 Manufacturing Process Analysis of Nitrocellulose (CN) Membrane
10.4 Industry Chain Structure of Nitrocellulose (CN) Membrane
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nitrocellulose (CN) Membrane Distributors
11.3 Nitrocellulose (CN) Membrane Customer
12 World Forecast Review for Nitrocellulose (CN) Membrane by Geographic Region
12.1 Global Nitrocellulose (CN) Membrane Market Size Forecast by Region
12.1.1 Global Nitrocellulose (CN) Membrane Forecast by Region (2027-2032)
12.1.2 Global Nitrocellulose (CN) Membrane Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nitrocellulose (CN) Membrane Forecast by Type (2027-2032)
12.7 Global Nitrocellulose (CN) Membrane Forecast by Application (2027-2032)
13 Key Players Analysis
13.1 Whatman
13.1.1 Whatman Company Information
13.1.2 Whatman Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.1.3 Whatman Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Whatman Main Business Overview
13.1.5 Whatman Latest Developments
13.2 Biosharp
13.2.1 Biosharp Company Information
13.2.2 Biosharp Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.2.3 Biosharp Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Biosharp Main Business Overview
13.2.5 Biosharp Latest Developments
13.3 Membrane Solutions
13.3.1 Membrane Solutions Company Information
13.3.2 Membrane Solutions Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.3.3 Membrane Solutions Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Membrane Solutions Main Business Overview
13.3.5 Membrane Solutions Latest Developments
13.4 Thermo Fisher
13.4.1 Thermo Fisher Company Information
13.4.2 Thermo Fisher Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.4.3 Thermo Fisher Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Thermo Fisher Main Business Overview
13.4.5 Thermo Fisher Latest Developments
13.5 Pall Corporation
13.5.1 Pall Corporation Company Information
13.5.2 Pall Corporation Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.5.3 Pall Corporation Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Pall Corporation Main Business Overview
13.5.5 Pall Corporation Latest Developments
13.6 Abcam
13.6.1 Abcam Company Information
13.6.2 Abcam Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.6.3 Abcam Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Abcam Main Business Overview
13.6.5 Abcam Latest Developments
13.7 Santa Cruz Biotechnology
13.7.1 Santa Cruz Biotechnology Company Information
13.7.2 Santa Cruz Biotechnology Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.7.3 Santa Cruz Biotechnology Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Santa Cruz Biotechnology Main Business Overview
13.7.5 Santa Cruz Biotechnology Latest Developments
13.8 Geno Technology
13.8.1 Geno Technology Company Information
13.8.2 Geno Technology Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.8.3 Geno Technology Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Geno Technology Main Business Overview
13.8.5 Geno Technology Latest Developments
13.9 MDI
13.9.1 MDI Company Information
13.9.2 MDI Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.9.3 MDI Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 MDI Main Business Overview
13.9.5 MDI Latest Developments
13.10 Macherey-Nagel
13.10.1 Macherey-Nagel Company Information
13.10.2 Macherey-Nagel Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.10.3 Macherey-Nagel Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Macherey-Nagel Main Business Overview
13.10.5 Macherey-Nagel Latest Developments
13.11 Bio-Rad Laboratories
13.11.1 Bio-Rad Laboratories Company Information
13.11.2 Bio-Rad Laboratories Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.11.3 Bio-Rad Laboratories Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Bio-Rad Laboratories Main Business Overview
13.11.5 Bio-Rad Laboratories Latest Developments
13.12 Advansta
13.12.1 Advansta Company Information
13.12.2 Advansta Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.12.3 Advansta Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Advansta Main Business Overview
13.12.5 Advansta Latest Developments
13.13 Interstate Specialty Products
13.13.1 Interstate Specialty Products Company Information
13.13.2 Interstate Specialty Products Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.13.3 Interstate Specialty Products Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Interstate Specialty Products Main Business Overview
13.13.5 Interstate Specialty Products Latest Developments
13.14 CHMLAB Group
13.14.1 CHMLAB Group Company Information
13.14.2 CHMLAB Group Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.14.3 CHMLAB Group Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 CHMLAB Group Main Business Overview
13.14.5 CHMLAB Group Latest Developments
13.15 Sartorius
13.15.1 Sartorius Company Information
13.15.2 Sartorius Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.15.3 Sartorius Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sartorius Main Business Overview
13.15.5 Sartorius Latest Developments
13.16 Cytiva
13.16.1 Cytiva Company Information
13.16.2 Cytiva Nitrocellulose (CN) Membrane Product Portfolios and Specifications
13.16.3 Cytiva Nitrocellulose (CN) Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Cytiva Main Business Overview
13.16.5 Cytiva Latest Developments
14 Research Findings and Conclusion